LG/Novartis Korea on joint marketing of fluvastatin.

LG Life Science (President: Kim In-cheol) and Novartis Korea announced a joint marketing agreement on Feb. 6 for the distribution of fluvastatin, a cholesterol lowering drug under the trade names of Xylap XL by LG and Lescol XL by Novartis Korea.

Lescol XL was approved by U. S. FDA as a sustained releasing tablet in 2002 and sold in more than 50 countries over the world at yearly 700 billio...